| 摘要 |
The present invention relates to novel fatty acid analogous of the general formula (I): R1- [xi - CH2]n - COOR2 wherein R1 is: a C6-C24 alkene with one or more double bonds and/or with one or more triple bonds, and/or a C6-C24 alkyne, and/or a C6-C24 alkyl substituted in one or several positions with o ne or more compounds selected from the group comprising fluoride, chloride, hydroxy, C1-C4 alkoxy, C1-C4 alkylthio, C2-C5 acyloxy or C1-C4 alkyl, and wherein R2 represents hydrogen or C1-C4 alkyl, and wherein n is an integer from 1 to 12, and wherein i is an odd number and indicates the position relative to COOR2, and wherein Xi independent of each other are selected fro m the group comprising O, S, SO, SO2, Se and CH2, and with the proviso that at least one of the Xi is not CH2, and with the proviso that if R1 is an alkye, then the carbon-carbon triple bond is positioned between the (.omega.-1) carbon and the (.omega.-2) carbon, or between the (.omega.-2) carbon and the (.omega.-3) carbon, or between the (.omega.-3) carbon and the (.omega.-4) carbon, a salt, prodrug or complex thereof, which can be used for the treatment and/or prevention of syndrome X, obesity, hypertension, fatty live r, diabetes, hyperglycaemia, hyperinsulinemia and stenosis. Further, the invention relates to a nutritionalcomposition comprising said fatty acid analogues, and a method for reducing the total weight, or the amount of adipose tissue in an animal.
|
